GlaxoSmithKline Gets Support From Leading Shareholders Over Elliott Management Shake-Up Bid -The Times
--GlaxoSmithKline PLC shareholders have backed the company over
concerns that activist U.S. hedge fund Elliott Management is set to
push for a shakeup, The Times reports.
--Several top 20 shareholders in the British pharmaceutical
company have contacted Chairman Jonathan Symonds to express support
for the board and its current strategy, according to The Times.
--Elliott hasn't yet revealed its intentions to the company but
has begun to engage with other leading shareholders, The Times
Full story: https://bit.ly/3hDWgn8
Write to Barcelona editors at email@example.com
(END) Dow Jones Newswires
May 17, 2021 09:17 ET (13:17 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.